Michael Wirtenberger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Michael Wirtenberger has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Alfons Meindl
Department of Gynaecology and Obstetrics, Klinikum rechts der Isar at the Technical University Munich, Germany
1 shared publicationBarbara Burwinkel
Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ) Im Neuenheimer Feld 580, 69120, Heidelberg, Germany 9 Helmholtz-university Group Molecular Epidemiology, German Cancer Research Center (DKFZ) Heidelberg, Germany
1 shared publicationBarbara Wappenschmidt
Division of Molecular Gynaeco-Oncology, Department of Gynaecology and Obstetrics, Center of Molecular Medicine Cologne (CMMC), University Hospital of Cologne Germany
1 shared publicationBernd Frank
Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ) Im Neuenheimer Feld 580, 69120, Heidelberg, Germany
1 shared publication- Bernhard Heinrich Friedrich Weber
Institute of Human Genetics, University of Regensburg, 93053 Regensburg, Germany
1 shared publication Claus R. Bartram
Institute of Human Genetics, University of Heidelberg Heidelberg, Germany
1 shared publication
Latest Publications
- Open Access
- 12 December 2005
- Published by Oxford University Press (OUP) in Carcinogenesis
- Vol. 27 (8) , 1655-1660
Interaction of Werner and Bloom syndrome genes with p53 in familial breast cancer
Mutations of the human RecQ helicase genes WRN and BLM lead to rare autosomal recessive disorders, Werner and Bloom syndromes, which are associated with premature ageing and cancer predisposition. We tested the hypothesis whether three polymorphic, non-conservative amino acid exchanges in WRN and BLM act as low-penetrance familial breast cancer risk factors. Moreover, we examined the putative impact of p53 Msp I 1798G>A, which is completely linked to p53PIN3 , a 16 bp insertion/duplication that has been associated with reduced p53 expression, on familial breast cancer risk. Genotyping analyses, performed on 816 BRCA1/2 mutation-negative German familial breast cancer patients and 1012 German controls, revealed a significant association of the WRN Cys 1367 Arg polymorphism with familial breast cancer (OR = 1.28, 95% CI 1.06–1.54) and high-risk familial breast cancer (OR = 1.32, 95% CI 1.06–1.65). The analysis of p53 Msp I 1798G>A, which is completely linked to p53PIN3 , showed a significantly increased familial breast cancer risk for carriers of the 16 bp insertion/duplication, following a recessive mode (OR = 2.15, 95% CI = 1.12–4.11). WRN Cys 1367 Arg , located in the C-terminus, the binding site of p53, is predicted to be damaging. The joint effect of WRN Cys 1367 Arg and p53 Msp I resulted in an increased breast cancer risk compared to the single polymorphisms (OR = 3.39, 95% CI 1.19–9.71). In conclusion, our study indicates the importance of inherited variants in the WRN and p53 genes for familial breast cancer susceptibility.
- 12 December 2005
- Published by Oxford University Press (OUP) in Carcinogenesis
- Vol. 27 (8) , 1655-1660
Open AccessInteraction of Werner and Bloom syndrome genes with p53 in familial breast cancer
Mutations of the human RecQ helicase genes WRN and BLM lead to rare autosomal recessive disorders, Werner and Bloom syndromes, which are associated with premature ageing and cancer predisposition. We tested the hypothesis whether three polymorphic, non-conservative amino acid exchanges in WRN and BLM act as low-penetrance familial breast cancer risk factors. Moreover, we examined the putative impact of p53 Msp I 1798G>A, which is completely linked to p53PIN3 , a 16 bp insertion/duplication that has been associated with reduced p53 expression, on familial breast cancer risk. Genotyping analyses, performed on 816 BRCA1/2 mutation-negative German familial breast cancer patients and 1012 German controls, revealed a significant association of the WRN Cys 1367 Arg polymorphism with familial breast cancer (OR = 1.28, 95% CI 1.06–1.54) and high-risk familial breast cancer (OR = 1.32, 95% CI 1.06–1.65). The analysis of p53 Msp I 1798G>A, which is completely linked to p53PIN3 , showed a significantly increased familial breast cancer risk for carriers of the 16 bp insertion/duplication, following a recessive mode (OR = 2.15, 95% CI = 1.12–4.11). WRN Cys 1367 Arg , located in the C-terminus, the binding site of p53, is predicted to be damaging. The joint effect of WRN Cys 1367 Arg and p53 Msp I resulted in an increased breast cancer risk compared to the single polymorphisms (OR = 3.39, 95% CI 1.19–9.71). In conclusion, our study indicates the importance of inherited variants in the WRN and p53 genes for familial breast cancer susceptibility.